Trial Profile
Late Phase 2 Study of OPC-12759 Ophthalmic Suspension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2016
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 19 Apr 2014 New trial record